Korean Infections Top 200; Hubei Adjusts New Cases: Virus Update [Investor's Business Daily]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: Investors Business Daily
Related news 2/20/2020 Boyd earnings jumped 52%, beating views. The U.S. casino stock has a perfect IBD Composite Rating of 99, but fell... Is Gilead Stock A Buy As It Takes Aim At The Deadly Coronavirus? Cases Top 70,000; China Congress May Delay Session: Virus Update China Ousts Officials As New Cases Soar By 15,000: Virus Update How A Two-Day Plunge Wiped Out This Biotech's Coronavirus Gains MGM Resorts Flashes Improved Stock Rating; Will Coronavirus Impact Winnings? Europe Stocks Edge Up With U.S. Futures; Bonds Dip: Markets Wrap Stocks Gain With U.S. Futures Before Powell Speaks: Markets Wrap 2 Growth Stocks With Unique Niche Markets Near Buy Points With Earnings Due The number of coronavirus cases in China topped 75,000, while concern grew over the pace of infections in other Asian countries as South Korea's soared past 200. Read: Hubei Revises Infection Count Again Due to Omitted Prison Tally Anxiety has crept back into global finan
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- Autoimmune Hepatitis Diagnosis and Treatment Market Size to Reach USD 19.15 Bn by 2032 [Yahoo! Finance]Yahoo! Finance
- Winn Awards Help Physicians Solve Healthcare Disparities [Yahoo! Finance]Yahoo! Finance
- Top Pictet Fund Manager Sees Biotech Stocks Joining AI-Euphoria [Yahoo! Finance]Yahoo! Finance
- Top Pictet Fund Manager Sees Biotech Stocks Joining AI-Euphoria [BNN Bloomberg (Canada)]BNN Bloomberg
- Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
GILD
Earnings
- 2/6/24 - Miss
GILD
Sec Filings
- 3/22/24 - Form 8-K
- 3/18/24 - Form PRE
- 3/14/24 - Form 8-K
- GILD's page on the SEC website